-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
January 01, 2024 - Transparency and
stakeholder input are essential to AHRQ. … anticoagulants: a systematic overview of
reviews on efficacy and safety, genotyping, self-monitoring, and stakeholder
-
cdsic.ahrq.gov/sites/default/files/2025-09/Quartz%20Assessment%20Report_To%20DTP_09.05.25.pdf
January 01, 2025 - Total KIIs Conducted by Stakeholder Type
Stakeholder Midpoint of Pilot Endpoint of Pilot Number of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-improving-health-systems-access.pdf
August 01, 2019 - A multidisciplinary stakeholder panel comprised of
individuals from Penn Medicine provided input for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
June 15, 2016 - Policies, Guidelines, Coverage, Stakeholder Information on Interventions of Interest
Intervention Current
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-expansion_research.pdf
April 01, 2012 - comprehensive framework
and design for a scalable and secure distributed research network.1,2 Detailed stakeholder … In addition, continuing development serves to
improve the usefulness of the stakeholder feedback, as
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
September 01, 2008 - AHRQ has taken steps to ensure stakeholder
involvement in the Effective Health Care Program studies;
-
digital.ahrq.gov/sites/default/files/SRF_Taxonomy%20of%20PC%20CDS%20Override%20Recommendations_508_0.pdf
July 01, 2024 - The CDSiC will also use the report to inform product development under
its Stakeholder and Community
-
cdsic.ahrq.gov/sites/default/files/2024-07/SRF_Taxonomy%20of%20PC%20CDS%20Override%20Recommendations_508_0.pdf
January 01, 2024 - The CDSiC will also use the report to inform product development under
its Stakeholder and Community
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
January 07, 2013 - The intended audience for the AHRQ
report is diverse and includes
stakeholder of all types in addition
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-nitric-oxide_research-protocol.pdf
September 06, 2016 - Fractional Exhaled Nitric Oxide Clinical Utility in Asthma Management
Source: www.effectivehealthcare.ahrq.gov
Published online: September 6, 2016
Evidence-based Practice Center Systematic Review Protocol
Project Title: Fractional Exhaled Nitric Oxide Clinical Utility in Asthma
Management
I. Background …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
December 01, 2009 - Layout 1
Background
Breast cancer is the second most common
malignancy of women, with over 180,000
new cases diagnosed each year in the
United States. Survival rates depend on the
stage of disease at diagnosis. Women
diagnosed with early stages of breast
cancer have a 5-year survival rate near 100
percent. However, …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
January 01, 2007 - Layout 1
Background
Rheumatoid and psoriatic arthritis are
among the most disabling forms of
arthritis. Rheumatoid arthritis (RA), which
affects 1 percent of the U.S. adult
population (or upwards of 2 million
individuals), is an autoimmune disease that
involves inflammation of the synovium (a
thin layer of tissue lin…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_disposition-comments.pdf
March 20, 2013 - Disposition of Comments Report for Interventions for Feeding and Nutrition in Cerebral Palsy
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1426
Published Online: March 20, 2013
Comparative Effectiveness Research Review Disposition of…
-
digital.ahrq.gov/sites/default/files/docs/publication/r13hs021825-kuperman-final-report-2015.pdf
January 01, 2015 - AMIA Health Policy Conference Series - Final Report
AMIA
Health Policy Conference Series
Final Progress Report
Principal Investigator
Douglas B. Fridsma, MD
Team Member Role
Susanna
Aguirre AMIA
Staff (2013-‐2014)
Salome
Aringo AMIA Staff (2012-‐2015)
Patricia
Flatley Brennan 201 P…
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2436
Published Online: March 24, 2017
Comparative Effectiveness Review Disposition of Comments Re…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
February 01, 2012 - Layout 1
Introduction
Antipsychotic medications are widely used
to treat several psychiatric disorders and
are commonly categorized into two classes.
First-generation antipsychotics (FGAs),
also known as typical antipsychotics, were
developed in the 1950s. Although they are
used to treat psychotic symptoms, they are…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2436
Published Online: March 24, 2017
Comparative Effectiveness Review Disposition of Comments Re…
-
digital.ahrq.gov/sites/default/files/docs/publication/r21hs018749-nease-final-report-2013.pdf
January 01, 2013 - Effects of Health Information Exchange Adoption on Ambulatory Testing Rates - Final Report
Grant Final Report
Grant ID: 5R21HS018749
Effects of Health Information Exchange Adoption on
Ambulatory Testing Rates
Inclusive Project Dates: 05/01/10 – 01/31/13
Principal Investigator:
Donald E. …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
August 10, 2016 - skin-cancer-protocol-160810
Source: www.effectivehealthcare.ahrq.gov
Published online: August 10, 2016
Evidence-based Practice Center Systematic Review Protocol
Project Title: Systematic Review of Treatments for Basal Cell and Squamous Cell
Carcinoma of the Skin
Initial publication date: June 23, 2016 …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_executive.pdf
October 01, 2011 - Layout 1
Background
Mildly elevated or decreased serum thyroid
stimulating hormone (TSH, also called
thyrotropin) levels are the most common
abnormalities related to thyroid function.
Subclinical thyroid dysfunction, defined as
an abnormal TSH with normal levels of
serum thyroid hormones (T3 and T4),
affects 5 perc…